**Author details**

Jacquelynne Cervantes-Torres† , Laura Montero† , Noé Rodríguez-Rodríguez, Edda Sciutto, Gladis Fragoso and Diana Torres-García\*

[11] Santoiemma PP, Powell DJ Jr. Tumor infiltrating lymphocytes in ovarian cancer. Cancer Biology & Therapy. 2015;**16**(6):807-820. DOI: 10.1080/15384047.2015.1040960

Understanding the Anti-Tumor Properties Mediated by the Synthetic Peptide GK-1

http://dx.doi.org/10.5772/intechopen.79833

75

[12] Chen J, Chen Z. The effect of immune microenvironment on the progression and prognosis of colorectal cancer. Medical Oncology. 2014;**31**(8):82. DOI: 10.1007/s12032-014-0082-9 [13] Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age.

[14] Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, Berger A, Camus M, Gillard M, Bruneval P, Fridman WH, Pagès F, Trajanoski Z, Galon J. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology. 2010;**138**(4):1429-1440. DOI: 10.1053/j.gastro.2009.10.057 [15] Angell H, Galon J. From the immune contexture to the Immunoscore: The role of prognostic and predictive immune markers in cancer. Current Opinion in Immunology.

[16] Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: Prognostic, predictive, and mechanistic signatures. Immunity. 2013;**39**(1):11-26.

[17] Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lym-

[18] Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: Moving beyond current

[19] Ishizuka M, Kawatsu M, Yamashita T, Ueno M, Takeuchi T. Low molecular weight immunomodulators produced by microorganisms. International Journal of Immuno-

[20] Fauci AS, Rosenberg SA, Sherwin SA, Dinarello CA, Longo DL, Lane HC. Immunomodulators in clinical medicine. NIH conference. Annals of Internal Medicine. 1987;

[21] Bellanti J. Immunology IV: Clinical applications in health and disease. World Allergy

[22] Pichichero ME. Improving vaccine delivery using novel adjuvant systems. Human

[23] Janin YL. Peptides with anticancer use or potential. Amino Acids. 2003;**25**(1):1-40. DOI:

[24] Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opinion on Investigational Drugs. 2006;**15**(8):933-946. DOI:

Organization Journal. 2012;**5**(8):94. DOI: 10.1097/WOX.0b013e3182641db0

phocytes. Science. 2002;**298**(5594):850-854. DOI: 10.1126/science.1076514

vaccines. Nature Medicine. 2004;**10**(9):909-915. DOI: 10.1038/nm1100

pharmacology. 1995;**17**(2):133-139. DOI: 10.1016/0192-0561(94)00086-4

Nature Immunology. 2018;**19**(2):108-119. DOI: 10.1038/s41590-017-0022-x

2013;**25**(2):261-267. DOI: 10.1016/j.coi.2013.03.004

**106**(3):421-433. DOI: 10.7326/0003-4819-106-3-421

Vaccines. 2008;**4**(4):262-270

10.1007/s00726-002-0349-x

10.1517/13543784.15.8.933

DOI: 10.1016/j.immuni.2013.07.008

\*Address all correspondence to: dianatg@comunidad.unam.mx

Biomedical Research Institute, National Autonomous University of Mexico, Ciudad de México, Mexico

† First joined authors
